YORBIK NEUROAI HEALTH AND CONSULTING LTDActive

Company number 12110646Private limited companyIncorporated 2019

Key figures

−£12,722+0.5%
Net assets 2025/26
-15 k-10 k-5 k02020/212021/222022/232023/242024/252025/26

Like most small UK companies, YORBIK NEUROAI HEALTH AND CONSULTING LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
020 k40 k2020/212021/222022/232023/242024/252025/26

Dividends

from the accounts
2025/26

Dividends paid in the financial year: £9,600.

History
2025/26£9,600
2024/25£18,300
2023/24£16,700
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand12,24917,16122,21020,99221,848
Total assets13,14937,28622,21020,99221,848
Total liabilities26,58239,01135,05233,77934,570
Net assets / total equity-13,433-1,725-12,842-12,787-12,722
Average number of employees111111
Dividends paid——16,70018,3009,600

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

The principal activity of the company during the year under review was Other human health activities. Manufacture of medical and dental instruments and supplies, Research and experimental development on biotechnology, Other research and experimental development on natural sciences and engineering, Other human health activities

As described in the company's latest filed accounts.

Summary: YORBIK NEUROAI HEALTH AND CONSULTING LTD

Company

YORBIK NEUROAI HEALTH AND CONSULTING LTD is a private limited company registered with Companies House under company number 12110646. It was incorporated on 18 Jul 2019. Its status is active. The registered office is in Twickenham (TW1). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500), research and experimental development on biotechnology (72110), other research and experimental development on natural sciences and engineering (72190), other human health activities (86900).

Accounts

The latest accounts in the database are for 2025/26 (period ending 30 Apr 2026); the company files small company accounts (filleted). Net assets were −£12,722, up 0.5% on the previous year. Cash at bank and in hand was £21,848. Total assets were £21,848 and total liabilities £34,570. The company had an average of 1 employee. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jan 2028. The next confirmation statement is due by 6 Jun 2027.